Luminare Saves Lives With AI
And we're starting with sepsis.
In a field of technology riddled with buzzwords and hype—in an industry obsessed with maintaining the status quo—Luminare is using AI the right way to do the right things: saving your patient’s lives, saving your healthcare worker’s time, and saving your hospital money.
We are doctors, nurses, administrators, and developers who want to save lives. We were an AI tech company before the ChatGPT-AI boom of 2022, and we’ll continue to be one long after the hype fades. And after we dethrone sepsis from its spot as the #1 killer in hospitals, we’re going to use our patented patient phenotyping algorithm to go after cancer, heart disease, and every other illness we can target with our technology.
Let’s begin with ending sepsis.
Published by Luminare
Using Machine Learning for Process Improvement in Sepsis Management
A Peer-Reviewed Article on Machine Learning
Who is Luminare
Sarma Velamuri, MD
Co-Founder + CEO, Luminare
Sarma Velamuri, MD is a world-class sepsis expert and thought leader committed to saving lives with AI.
Dr. Velamuri is a published, board-certified Internal Medicine physician. Among his many accomplishments, he was a hospitalist at Baylor College of Medicine (BCM), serves on the Catholic Health Initiatives (CHI) sepsis committee, and was appointed as the 2018 Sepsis Champion for HCA-Houston.
Read More →
He’s also served as the Medical Director of a Fortune 500 company and was an active board member at the Texas Medical Center Sepsis Collaborative. Dr. Velamuri presented as the keynote speaker for Stanford University’s Hack from Home healthcare innovation hackathon and has spoken at various other premiere events including the FBI’s Biotechnology Security Summit, UC Berkeley’s Hacks for COVID 2020 panel and the Mayo Clinic Platfrom_Accelerate’s showcase in 2024.
To book Dr. Velamuri for consulting, speaking engagements, or media appearances, email [email protected]
Senior Leadership
Sarma
Velamuri,
MD
Co-Founder + CEO
Marcus
Rydberg
Co-Founder + CTO
James
Hearn
VP of Operations
Meghan
Wittorf
Financial Controller
Board of Directors
Doug
Erwin
Chairman of the Board
John
Hageman
Board Member + General Counsel
Keith
Kreuer
Board Advisor
Luminare's PublicHealth™ Work
Our game-changing platform, Innoculate, was used to rapidly administer millions of vaccinations during the pandemic.
Innoculate (Innovation+Inoculation) is an end-to-end solution designed for public health departments, large enterprise or educational systems, hospitals, pharmacies, and any other organization tasked with administering and managing vaccines. Whether tasked with standard inoculations or organizing a drive-through mass vaccination event, Innoculate will meet your needs. We also offer turnkey solutions through various partners to provide support to underserved communities.
By deploying Innoculate, a vaccine administrator can maximize the throughput of patients based on various criteria (such as availability), track vaccines at a granular level, and report on efficacy data. Innoculate is currently deployed across various cities and counties to help with vaccine distribution at office and drive-through clinics.
The landscape of vaccine needs has obviously gone through drastic change between 2020 and now—as has our primary focus as a company. But if you’re interested in Innoculate as a vaccine administration and management system, please reach out to us at [email protected]
Featured In:
Luminare has had over 75 press and media mentions in the last two years alone. Including coverage on ABC, CBS, NBC, CNN, Forbes, Associated Press, Texas Monthly, Houston Chronicle, and more.
